Goldman Sachs’s Imunon IMNN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-9
Closed -$56K 7177
2014
Q4
$56K Hold
9
﹤0.01% 6776
2014
Q3
$71K Hold
9
﹤0.01% 6721
2014
Q2
$83K Sell
9
-99
-92% -$884K ﹤0.01% 6625
2014
Q1
$996K Sell
108
-65
-38% -$677K ﹤0.01% 4675
2013
Q4
$1.85M Sell
173
-2
-1% -$24K ﹤0.01% 4146
2013
Q3
$2.48M Hold
175
﹤0.01% 3713
2013
Q2
$2.2M Buy
+175
New +$2.43M ﹤0.01% 3630

Other funds holding IMNN

Goldman Sachs's IMNN Position: Q1 2021 in Review

Goldman Sachs sold out of Imunon (IMNN) in Q1 2021, closing a stake of 62 shares — an estimated $9K sold.

Goldman Sachs first reported a position in IMNN in Q2 2013 and held it in 9 quarters. The position peaked at $328K in Q4 2014. 40 funds tracked by Wall St. Rank hold IMNN as of Q1 2021.

  • Goldman Sachs reported no remaining Imunon position as of Q1 2021 after selling out during the quarter.
  • Goldman Sachs sold 62 Imunon shares in Q1 2021, an estimated $9K.
  • Goldman Sachs first reported a position in Imunon in Q2 2013 and held it in 9 quarters.
  • Goldman Sachs's Imunon position peaked at $328K in Q4 2014.
  • 40 funds tracked by Wall St. Rank held Imunon as of Q1 2021.

Based on Goldman Sachs's 13F filing for Q1 2021, filed 17 May 2021.